Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CXCR5 antibody (N-Term)

The Rabbit Polyclonal anti-CXCR5 antibody has been validated for WB. It is suitable to detect CXCR5 in samples from Human. There are 3+ publications available.
Catalog No. ABIN1881245

Quick Overview for CXCR5 antibody (N-Term) (ABIN1881245)

Target

See all CXCR5 Antibodies
CXCR5 (Chemokine (C-X-C Motif) Receptor 5 (CXCR5))

Reactivity

  • 100
  • 53
  • 47
  • 5
  • 5
  • 2
  • 1
  • 1
Human

Host

  • 87
  • 12
  • 3
  • 2
  • 1
Rabbit

Clonality

  • 61
  • 42
  • 1
Polyclonal

Conjugate

  • 38
  • 8
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This CXCR5 antibody is un-conjugated

Application

  • 51
  • 33
  • 28
  • 13
  • 12
  • 8
  • 7
  • 5
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

RB41684
  • Binding Specificity

    • 12
    • 7
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-30, N-Term

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This CXCR5 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human CXCR5.

    Isotype

    Ig Fraction
  • Application Notes

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Expiry Date

    6 months
  • Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Lee, Shiao, Wu, Chen, Hsu, Tsai, Tsai: "Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis." in: The Journal of rheumatology, Vol. 37, Issue 1, pp. 45-52, (2009) (PubMed).

    Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

  • Target

    CXCR5 (Chemokine (C-X-C Motif) Receptor 5 (CXCR5))

    Alternative Name

    CXCR5

    Background

    This gene was identified as a gene specifically expressed in Burkitt's lymphoma and lymphatic tissues. The protein encoded by this gene is predicted to be a seven transmembrane G protein- coupled receptor and belongs to the CXC chemokine receptor family. BLC, a B-lymphocyte chemoattractant, was identified to be a specific ligand for this receptor. Studies of this gene and its mouse conterpart strongly suggest the essential function of this gene in B cell migration and localization within specific anatomic compartments, such as follicles in lymph nodes as well as in spleen. Two alternatively spliced variants of this gene exist.

    Molecular Weight

    41955

    NCBI Accession

    NP_001707, NP_116743

    UniProt

    P32302
You are here:
Chat with us!